期刊文献+

电话随访对乳腺癌患者服药依从性和生活质量的影响 被引量:118

Effect of nurse-led follow-up on medication adherence and quality of life of patients with breast cancer
原文传递
导出
摘要 目的评价护士主导的电话随访对术后辅助内分泌治疗乳腺癌患者服药依从性和生活质量的影响。方法采用随机对照试验设计。患者被分为干预组51例和对照组44例。两组均发放《乳腺癌患者内分泌治疗服药指导手册》和带闹铃的药盒。两组均采取常规护理措施,参加医院组织的每月1次的疾病相关知识讲座,自愿通过医院提供的网络平台学习和交流疾病治疗相关知识,对干预组的患者实施护士主导的电话随访。分别评价两组患者在干预3个月和6个月时的服药依从率和生活质量。结果干预组在干预3个月、6个月时的服药依从率均高于对照组(P<0.05),生活质量中内分泌症状维度得分高于对照组(P<0.05)。结论护士主导的电话随访可以提高术后辅助内分泌治疗乳腺癌患者的短期服药依从率,改善内分泌相关症状。 Objective To evaluate the effect of nurse-led individualized telephone follow-up on medication adherence and quality of life of breast cancer patients receiving adjuvant hormonal therapy. Methods A randomized controlled trial was conducted. The patients were randomly divided into two groups,51 in the intervention group and 44 in the control group. All the patients got the special guide for them and alarm box,routine nursing care, got related knowledge by lectures in the hospital and network platform. In addition,the patients in the intervention group receiving nurse-led individualized follow-up. The patients' medication adherence and quality of life were eval- uated after 3 months and 6 months. Results After 6-month nurse-led individualized telephone follow-up,the medi cation possession ration and scores of endocrine symptom subscale of patients in the intervention group were signifi- cantly higher than that of patients in the control group (P〈0.05). Conclusions Nurse-led individualized follow-up could significantly enhance the rate of medication adherence and endocrine symptom during the first six month of hormonal therapy for breast cancer patients.
出处 《中华护理杂志》 CSCD 北大核心 2015年第1期69-73,共5页 Chinese Journal of Nursing
基金 2012年上海市卫生局局级科研项目(2012-96) 复旦大学护理科研项目(FNSF201102)
关键词 乳腺肿瘤 药物疗法 病人依从 护理 Breast Neoplasms Drug Therapy Patient Compliance Nursing Care
  • 相关文献

参考文献26

  • 1Jemal A,Bray F,Center MM,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(2):69-90.
  • 2中华人民共和国卫生部.中国卫生部卫生统计年鉴[EB/OL]. (2012-09-14) [2013-12-12]. http://www, moh. gov. en/ publicflles/business/htmlfiles/ zwgkzt/ ptjnj/ year2010/ index2010. html.
  • 3NCCN.National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology,Breast Cancer[EB/OL].[2012-09-14].http://www.nccn.org/professionals/physician_gls/f_guidelines.asp]breast.
  • 4Mccowan C,Shearer J,Donnan PT,et al.Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer[J].Br J Cancer,2008,99(11):1763-1768.
  • 5Hershman DL,Kushi LH,Shao T,et al.Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of8,769 early-stage breast cancer patients[J].J Clin Oncol,2010,28(27):4120-4128.
  • 6Nekhlyudov L,Li L,Ross-Degnan D,et al.Five-year patterns of adjuvant hormonal therapy use,persistence,and adherence among insured women with early-stage breast cancer[J].Breast Cancer Res Treat,2011,130(2):681-689.
  • 7Huiart L,Dell'Aniello S,Suissa S.Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer[J].Br J Cancer,2011,104(10):1558-1563.
  • 8Weaver KE,Camacho F,Hwang W,et al.Adherence to adjuvant hormonal therapy and its relationship to breast cancer recurrence and survival among low-income women[J].Am J Clin Oncol,2013,36(2):181-187.
  • 9朱叶卉,黄嘉玲,胡雁,陆箴琦,裘佳佳,顾荣丰,徐蓓赟,严霞,吴密彬.乳腺癌患者内分泌治疗的服药依从性研究[J].护理学杂志(外科版),2013,28(8):43-45. 被引量:17
  • 10Kimman ML,Bloebaum MM,Dirksen CD,et al.Patient satisfaction with nurse-led telephone follow-up after curative treatment for breast cancer[J].BMC Cancer,2010,10:174.

二级参考文献18

  • 1吴世凯,宋三泰.第三代芳香化酶抑制剂临床应用的常见不良反应[J].中国药物警戒,2006,3(2):68-71. 被引量:14
  • 2中华人民共和国卫生部.中国卫生部卫生统计年鉴EB/OL].(2012-09-14)[2012-12-01].http://www.moh.gov.cn/publicfiles/business/htmlfiles/zwgkzt/ptjnj/year2010/index2010.html.
  • 3NCCN.National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology,Breast Cancer[EB/OL].(2012-09-14)[2012-12-01].http://www.nccn.org/professionals/physician_ gls/f _ guidelines.asp #breast.
  • 4Hershman D L,Shao T,Kushi L H,et al.Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer[J].Breast Cancer Res Treat,2011,126(2):529-537.
  • 5Liu H,Colin C E,Miller L G,et al.A comparison study of multiple measures of adherence to HIV protease inhi-bitors[J].Ann Intern Med,2001,134(10):968-977.
  • 6Darkow T,Henk H J,Thomas S K,et al.Treatment interruptions and non-adherence with imatinib and associated healthcare costs:a retrospective analysis among managed care patients with chronic myelogenous leukaemia[J].Pharmacoeconomics,2007,25 (6):481-496.
  • 7Noens L,van Lierde M A,De Bock R,et al.Prevalence,determinants,and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia:the ADAGIO study[J].Blood,2009,113(22):5401-5411.
  • 8Ziller V,Kalder M,Albert U S,et al.Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer[J].Ann Oncol,2009,20 (3):431-436.
  • 9Fink A K,Gurwitz J,Rakowski W,et al.Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer[J].J Clin Oncol,2004,22(16):3309-3315.
  • 10Osterberg L,Blaschke T.Adherence to medication[J].N Engl J Med,2005,353(5):487-497.

共引文献17

同被引文献1077

引证文献118

二级引证文献882

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部